Promotions & Moves

Altasciences Appoints Senior Director Compliance and RA

Paul will lead the development of the company’s regulatory offering, from preclinical to clinical research, for all services

Altasciences has appointed Paul Sidney to its Compliance and Regulatory Affairs team as senior director. Paul will lead the development of the company’s regulatory offering, from preclinical to clinical research, for all services. He brings extensive experience from Charles River Laboratories and his direct involvement in various key regulatory initiatives in the drug development field.

Paul has an active role in the industry as a member of the SQA (BASS, GLPSS, and CSS) and as the founding president of the Canadian regional chapter of the SQA (CCSQA). As a highly esteemed key opinion leader, he routinely presents on a broad range of regulatory topics at conferences worldwide and at academic and government institutions.

“Several leaders have initiated their career under Paul’s direction, which attests to his capacity to successfully transfer knowledge and cultivate talent. Altasciences is thrilled and honored to welcome Paul to our team, as we continue to develop and expand our regulatory offering and expertise,” said David Grégoire, vice president, Compliance and Regulatory Affairs, at Altasciences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters